 | • レポートコード：QYR2104Z2002 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、変形性関節症鎮痛剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射、外部）、用途別市場規模（医療、パーソナルケア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・変形性関節症鎮痛剤の市場動向 ・企業の競争状況、市場シェア ・変形性関節症鎮痛剤の種類別市場規模（経口、注射、外部） ・変形性関節症鎮痛剤の用途別市場規模（医療、パーソナルケア） ・変形性関節症鎮痛剤の北米市場規模2016-2027（アメリカ、カナダ） ・変形性関節症鎮痛剤のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・変形性関節症鎮痛剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・変形性関節症鎮痛剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・変形性関節症鎮痛剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Johnson & Johnson、GlaxoSmithKline、Bayer、Eli Lilly、Novartis、Sanofi、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical、Abiogen Pharma） ・結論 |
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
Geographically, the global Drugs for Osteoarthritis Pain market has been segmented into North America, Europe, China, Japan, Rest of Asia (RoA), and Rest of World (RoW). The North America held the largest share in the global market, its revenue of global market exceeds 38% in 2017. The next is Europe.
Market Analysis and Insights: Global Drugs for Osteoarthritis Pain Market
The global Drugs for Osteoarthritis Pain market size is projected to reach US$ 12370 million by 2026, from US$ 8356.4 million in 2019, at a CAGR of 5.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drugs for Osteoarthritis Pain market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drugs for Osteoarthritis Pain market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drugs for Osteoarthritis Pain market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drugs for Osteoarthritis Pain market.
Global Drugs for Osteoarthritis Pain Scope and Market Size
Drugs for Osteoarthritis Pain market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Osteoarthritis Pain market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral
Injection
External
Segment by Application
Medical Care
Personal Care
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Bayer
Eli Lilly
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Drugs for Osteoarthritis Pain Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Osteoarthritis Pain Market Perspective (2016-2027)
2.2 Drugs for Osteoarthritis Pain Growth Trends by Regions
2.2.1 Drugs for Osteoarthritis Pain Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drugs for Osteoarthritis Pain Historic Market Share by Regions (2016-2021)
2.2.3 Drugs for Osteoarthritis Pain Forecasted Market Size by Regions (2022-2027)
2.3 Drugs for Osteoarthritis Pain Industry Dynamic
2.3.1 Drugs for Osteoarthritis Pain Market Trends
2.3.2 Drugs for Osteoarthritis Pain Market Drivers
2.3.3 Drugs for Osteoarthritis Pain Market Challenges
2.3.4 Drugs for Osteoarthritis Pain Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue
3.1.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue (2016-2021)
3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2016-2021)
3.2 Global Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drugs for Osteoarthritis Pain Revenue
3.4 Global Drugs for Osteoarthritis Pain Market Concentration Ratio
3.4.1 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Osteoarthritis Pain Revenue in 2020
3.5 Drugs for Osteoarthritis Pain Key Players Head office and Area Served
3.6 Key Players Drugs for Osteoarthritis Pain Product Solution and Service
3.7 Date of Enter into Drugs for Osteoarthritis Pain Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Osteoarthritis Pain Breakdown Data by Type
4.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Type (2016-2021)
4.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2022-2027)
5 Drugs for Osteoarthritis Pain Breakdown Data by Application
5.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Application (2016-2021)
5.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Drugs for Osteoarthritis Pain Market Size (2016-2027)
6.2 North America Drugs for Osteoarthritis Pain Market Size by Type
6.2.1 North America Drugs for Osteoarthritis Pain Market Size by Type (2016-2021)
6.2.2 North America Drugs for Osteoarthritis Pain Market Size by Type (2022-2027)
6.2.3 North America Drugs for Osteoarthritis Pain Market Size by Type (2016-2027)
6.3 North America Drugs for Osteoarthritis Pain Market Size by Application
6.3.1 North America Drugs for Osteoarthritis Pain Market Size by Application (2016-2021)
6.3.2 North America Drugs for Osteoarthritis Pain Market Size by Application (2022-2027)
6.3.3 North America Drugs for Osteoarthritis Pain Market Size by Application (2016-2027)
6.4 North America Drugs for Osteoarthritis Pain Market Size by Country
6.4.1 North America Drugs for Osteoarthritis Pain Market Size by Country (2016-2021)
6.4.2 North America Drugs for Osteoarthritis Pain Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Drugs for Osteoarthritis Pain Market Size (2016-2027)
7.2 Europe Drugs for Osteoarthritis Pain Market Size by Type
7.2.1 Europe Drugs for Osteoarthritis Pain Market Size by Type (2016-2021)
7.2.2 Europe Drugs for Osteoarthritis Pain Market Size by Type (2022-2027)
7.2.3 Europe Drugs for Osteoarthritis Pain Market Size by Type (2016-2027)
7.3 Europe Drugs for Osteoarthritis Pain Market Size by Application
7.3.1 Europe Drugs for Osteoarthritis Pain Market Size by Application (2016-2021)
7.3.2 Europe Drugs for Osteoarthritis Pain Market Size by Application (2022-2027)
7.3.3 Europe Drugs for Osteoarthritis Pain Market Size by Application (2016-2027)
7.4 Europe Drugs for Osteoarthritis Pain Market Size by Country
7.4.1 Europe Drugs for Osteoarthritis Pain Market Size by Country (2016-2021)
7.4.2 Europe Drugs for Osteoarthritis Pain Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size (2016-2027)
8.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Type
8.2.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Type (2016-2027)
8.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Application
8.3.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Application (2016-2027)
8.4 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region
8.4.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drugs for Osteoarthritis Pain Market Size (2016-2027)
9.2 Latin America Drugs for Osteoarthritis Pain Market Size by Type
9.2.1 Latin America Drugs for Osteoarthritis Pain Market Size by Type (2016-2021)
9.2.2 Latin America Drugs for Osteoarthritis Pain Market Size by Type (2022-2027)
9.2.3 Latin America Drugs for Osteoarthritis Pain Market Size by Type (2016-2027)
9.3 Latin America Drugs for Osteoarthritis Pain Market Size by Application
9.3.1 Latin America Drugs for Osteoarthritis Pain Market Size by Application (2016-2021)
9.3.2 Latin America Drugs for Osteoarthritis Pain Market Size by Application (2022-2027)
9.3.3 Latin America Drugs for Osteoarthritis Pain Market Size by Application (2016-2027)
9.4 Latin America Drugs for Osteoarthritis Pain Market Size by Country
9.4.1 Latin America Drugs for Osteoarthritis Pain Market Size by Country (2016-2021)
9.4.2 Latin America Drugs for Osteoarthritis Pain Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size (2016-2027)
10.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type
10.2.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2016-2027)
10.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application
10.3.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2016-2027)
10.4 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country
10.4.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Drugs for Osteoarthritis Pain Introduction
11.1.4 Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Introduction
11.2.4 Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Introduction
11.3.4 GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Drugs for Osteoarthritis Pain Introduction
11.4.4 Bayer Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Introduction
11.5.4 Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.5.5 Eli Lilly Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Drugs for Osteoarthritis Pain Introduction
11.6.4 Novartis Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Drugs for Osteoarthritis Pain Introduction
11.7.4 Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Details
11.8.2 Horizon Pharma Business Overview
11.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Introduction
11.8.4 Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.8.5 Horizon Pharma Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Drugs for Osteoarthritis Pain Introduction
11.9.4 Abbott Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.9.5 Abbott Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Drugs for Osteoarthritis Pain Introduction
11.10.4 Mylan Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.10.5 Mylan Recent Development
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Details
11.11.2 Daiichi Sankyo Business Overview
11.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Introduction
11.11.4 Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.11.5 Daiichi Sankyo Recent Development
11.12 TEVA
11.12.1 TEVA Company Details
11.12.2 TEVA Business Overview
11.12.3 TEVA Drugs for Osteoarthritis Pain Introduction
11.12.4 TEVA Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.12.5 TEVA Recent Development
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Details
11.13.2 Almatica Pharma Business Overview
11.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Introduction
11.13.4 Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.13.5 Almatica Pharma Recent Development
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Details
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Introduction
11.14.4 Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.14.5 Astellas Pharma Recent Development
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Details
11.15.2 Tide Pharmaceutical Business Overview
11.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Introduction
11.15.4 Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.15.5 Tide Pharmaceutical Recent Development
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Details
11.16.2 Iroko Pharmaceuticals Business Overview
11.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Introduction
11.16.4 Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.16.5 Iroko Pharmaceuticals Recent Development
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Details
11.17.2 Hengrui Pharmaceutical Business Overview
11.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Introduction
11.17.4 Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.17.5 Hengrui Pharmaceutical Recent Development
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Details
11.18.2 Abiogen Pharma Business Overview
11.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Introduction
11.18.4 Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2016-2021)
11.18.5 Abiogen Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of External
Table 5. Global Drugs for Osteoarthritis Pain Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Drugs for Osteoarthritis Pain Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Drugs for Osteoarthritis Pain Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Drugs for Osteoarthritis Pain Market Share by Regions (2016-2021)
Table 9. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Drugs for Osteoarthritis Pain Market Share by Regions (2022-2027)
Table 11. Drugs for Osteoarthritis Pain Market Trends
Table 12. Drugs for Osteoarthritis Pain Market Drivers
Table 13. Drugs for Osteoarthritis Pain Market Challenges
Table 14. Drugs for Osteoarthritis Pain Market Restraints
Table 15. Global Drugs for Osteoarthritis Pain Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Drugs for Osteoarthritis Pain Market Share by Players (2016-2021)
Table 17. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Osteoarthritis Pain as of 2020)
Table 18. Ranking of Global Top Drugs for Osteoarthritis Pain Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Drugs for Osteoarthritis Pain Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Drugs for Osteoarthritis Pain Product Solution and Service
Table 22. Date of Enter into Drugs for Osteoarthritis Pain Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drugs for Osteoarthritis Pain Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2016-2021)
Table 26. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Drugs for Osteoarthritis Pain Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2016-2021)
Table 30. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Drugs for Osteoarthritis Pain Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Drugs for Osteoarthritis Pain Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Drugs for Osteoarthritis Pain Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Drugs for Osteoarthritis Pain Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Drugs for Osteoarthritis Pain Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Drugs for Osteoarthritis Pain Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Drugs for Osteoarthritis Pain Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Drugs for Osteoarthritis Pain Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Drugs for Osteoarthritis Pain Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Drugs for Osteoarthritis Pain Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Drugs for Osteoarthritis Pain Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Drugs for Osteoarthritis Pain Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Drugs for Osteoarthritis Pain Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Drugs for Osteoarthritis Pain Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Drugs for Osteoarthritis Pain Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Drugs for Osteoarthritis Pain Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Drugs for Osteoarthritis Pain Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Drugs for Osteoarthritis Pain Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Drugs for Osteoarthritis Pain Product
Table 65. Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Johnson & Johnson Company Details
Table 68. Johnson & Johnson Business Overview
Table 69. Johnson & Johnson Drugs for Osteoarthritis Pain Product
Table 70. Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 71. Johnson & Johnson Recent Development
Table 72. GlaxoSmithKline Company Details
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Drugs for Osteoarthritis Pain Product
Table 75. GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Bayer Company Details
Table 78. Bayer Business Overview
Table 79. Bayer Drugs for Osteoarthritis Pain Product
Table 80. Bayer Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 81. Bayer Recent Development
Table 82. Eli Lilly Company Details
Table 83. Eli Lilly Business Overview
Table 84. Eli Lilly Drugs for Osteoarthritis Pain Product
Table 85. Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 86. Eli Lilly Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Drugs for Osteoarthritis Pain Product
Table 90. Novartis Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Drugs for Osteoarthritis Pain Product
Table 95. Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 96. Sanofi Recent Development
Table 97. Horizon Pharma Company Details
Table 98. Horizon Pharma Business Overview
Table 99. Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 100. Horizon Pharma Recent Development
Table 101. Abbott Company Details
Table 102. Abbott Business Overview
Table 103. Abbott Drugs for Osteoarthritis Pain Product
Table 104. Abbott Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 105. Abbott Recent Development
Table 106. Mylan Company Details
Table 107. Mylan Business Overview
Table 108. Mylan Drugs for Osteoarthritis Pain Product
Table 109. Mylan Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 110. Mylan Recent Development
Table 111. Daiichi Sankyo Company Details
Table 112. Daiichi Sankyo Business Overview
Table 113. Daiichi Sankyo Drugs for Osteoarthritis Pain Product
Table 114. Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 115. Daiichi Sankyo Recent Development
Table 116. TEVA Company Details
Table 117. TEVA Business Overview
Table 118. TEVA Drugs for Osteoarthritis Pain Product
Table 119. TEVA Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 120. TEVA Recent Development
Table 121. Almatica Pharma Company Details
Table 122. Almatica Pharma Business Overview
Table 123. Almatica Pharma Drugs for Osteoarthritis Pain Product
Table 124. Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 125. Almatica Pharma Recent Development
Table 126. Astellas Pharma Company Details
Table 127. Astellas Pharma Business Overview
Table 128. Astellas Pharma Drugs for Osteoarthritis Pain Product
Table 129. Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 130. Astellas Pharma Recent Development
Table 131. Tide Pharmaceutical Company Details
Table 132. Tide Pharmaceutical Business Overview
Table 133. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 134. Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 135. Tide Pharmaceutical Recent Development
Table 136. Iroko Pharmaceuticals Company Details
Table 137. Iroko Pharmaceuticals Business Overview
Table 138. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product
Table 139. Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 140. Iroko Pharmaceuticals Recent Development
Table 141. Hengrui Pharmaceutical Company Details
Table 142. Hengrui Pharmaceutical Business Overview
Table 143. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 144. Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 145. Hengrui Pharmaceutical Recent Development
Table 146. Abiogen Pharma Company Details
Table 147. Abiogen Pharma Business Overview
Table 148. Abiogen Pharma Drugs for Osteoarthritis Pain Product
Table 149. Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2016-2021) & (US$ Million)
Table 150. Abiogen Pharma Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Osteoarthritis Pain Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. External Features
Figure 5. Global Drugs for Osteoarthritis Pain Market Share by Application: 2020 VS 2027
Figure 6. Medical Care Case Studies
Figure 7. Personal Care Case Studies
Figure 8. Drugs for Osteoarthritis Pain Report Years Considered
Figure 9. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Drugs for Osteoarthritis Pain Market Share by Regions: 2020 VS 2027
Figure 12. Global Drugs for Osteoarthritis Pain Market Share by Regions (2022-2027)
Figure 13. Global Drugs for Osteoarthritis Pain Market Share by Players in 2020
Figure 14. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Osteoarthritis Pain as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2020
Figure 16. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2016-2021)
Figure 17. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2022-2027)
Figure 18. North America Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Drugs for Osteoarthritis Pain Market Share by Type (2016-2027)
Figure 20. North America Drugs for Osteoarthritis Pain Market Share by Application (2016-2027)
Figure 21. North America Drugs for Osteoarthritis Pain Market Share by Country (2016-2027)
Figure 22. United States Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Drugs for Osteoarthritis Pain Market Share by Type (2016-2027)
Figure 26. Europe Drugs for Osteoarthritis Pain Market Share by Application (2016-2027)
Figure 27. Europe Drugs for Osteoarthritis Pain Market Share by Country (2016-2027)
Figure 28. Germany Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Drugs for Osteoarthritis Pain Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Drugs for Osteoarthritis Pain Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Drugs for Osteoarthritis Pain Market Share by Region (2016-2027)
Figure 38. China Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Drugs for Osteoarthritis Pain Market Share by Type (2016-2027)
Figure 46. Latin America Drugs for Osteoarthritis Pain Market Share by Application (2016-2027)
Figure 47. Latin America Drugs for Osteoarthritis Pain Market Share by Country (2016-2027)
Figure 48. Mexico Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Country (2016-2027)
Figure 54. Turkey Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Drugs for Osteoarthritis Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 58. Johnson & Johnson Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 64. Horizon Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 65. Abbott Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 66. Mylan Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 67. Daiichi Sankyo Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 68. TEVA Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 69. Almatica Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 70. Astellas Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 71. Tide Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 72. Iroko Pharmaceuticals Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 73. Hengrui Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 74. Abiogen Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の変形性関節症用鎮痛剤市場 2021：企業別、地域別、種類・用途別 The Osteoarthritis Pain Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…- 世界の股関節変形性股関節症鎮痛剤市場 2021：企業別、地域別、種類・用途別 The Hip Osteoarthritis Pain Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の股関節変形性股関節症鎮痛薬市場 2021：企業別、地域別、種類・用途別 The Hip Osteoarthritis Pain Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界の変形性関節症治療溶液市場 2021：企業別、地域別、種類・用途別 The Osteoarthritis Pain Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の変形性関節症（OA）疼痛薬市場 2021：企業別、地域別、種類・用途別 The Medicine for Osteoarthritis Pain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…